Rocket Lab’s Highly Anticipated Neutron Flight May Be Delayed. What That Means for RKLB Stock.

Rocket Lab Corporation (RKLB) is building a name for itself in the space industry, launching satellites and spacecraft with its Electron rocket while developing larger vehicles for more ambitious missions. 

Looking to take its launch business to the next level, Rocket Lab is betting heavily on Neutron, a reusable medium-lift rocket built to deploy satellite constellations, handle national security missions, and eventually support exploration of the Moon, Mars, and beyond. The rocket is also positioned to take on SpaceX’s (SPCX) Falcon 9 in the medium-lift launch market.

Neutron recently grabbed headlines for a reason investors may not like. Rocket Lab’s shares fell recently after the company signaled that the window for Neutron’s first flight this year is narrowing. While Rocket Lab still expects the rocket to reach the launchpad in the fourth quarter of 2026, it stopped short of maintaining its previous goal of launching before year-end. That raises the possibility that Neutron’s debut could slip into 2027.

CEO Peter Beck said production remains aligned with the Q4 2026 pad-delivery target, but the company is balancing the timing of its first launch against the need to scale smoothly toward its tenth flight.

The potential delay came just as Rocket Lab reported a record Q2 on Aug. 10, shifting investors’ attention from the company’s strong financial performance to what the Neutron timeline could mean for RKLB stock going forward.

About Rocket Lab Stock

Founded in 2006 and headquartered in Long Beach, California, Rocket Lab has grown from a launch-focused startup into a full-scale, end-to-end space company serving both commercial and government customers. The company designs, builds, and launches rockets while also developing spacecraft and broader space systems, allowing it to support missions across much of the space value chain.

Its flagship Electron rocket is a lightweight launch vehicle designed primarily to deploy small satellites into low Earth orbit. Electron has launched more than 260 satellites, while more than 1,700 satellites carrying Rocket Lab technology are already in orbit, highlighting the company’s growing footprint in space.

Rocket Lab is also preparing for its next major step with Neutron, a reusable medium-lift rocket designed to support large satellite constellations and deep-space missions, with a planned payload capacity of up to 13,000 kilograms. Beyond launches, Rocket Lab manufactures satellites and provides mission management and other space systems. With a market cap of $46.3 billion, the company is positioning itself as an increasingly important player in the expanding space economy.

If you have been watching RKLB stock lately, you know it has been a bit of a roller coaster. After a powerful run, shares touched a high of $151 in late May, helped by Rocket Lab’s rising revenue, growing backlog, increasing defense demand, and a steady stream of contracts and acquisitions. But since then, the stock has given back a big chunk of those gains and is now about 47% below that peak.

The pullback has largely been tied to broader developments across the space sector. When SpaceX went public on June 12, it pulled a lot of investor attention – and capital – away from smaller space stocks like Rocket Lab. Meanwhile, SpaceX’s growing competitive threat has investors thinking twice. Its upcoming Starship, the company’s largest rocket yet, could potentially handle bigger payloads while putting pressure on launch prices. That has raised questions about whether some of the more optimistic expectations for Rocket Lab can hold up. Concerns about potentially higher interest rates have added another layer of pressure to the stock’s valuation.

Yet, in 2026, RKLB is up 15.18% and looking at the bigger picture, it rose 85% over the past 52 weeks. Even with some recent pullback, the overall story still looks positive.

Technically, RKLB stock is showing a more balanced picture after the pullback. The 14-day RSI is at 53.51, putting the stock close to the middle of the range and suggesting that neither buyers nor sellers have a clear upper hand right now. Plus, the MACD oscillator is flashing a more encouraging signal. The MACD line has moved above the signal line, while the histogram has turned positive, pointing to improving upward momentum.

The recent weakness has not completely erased the stock’s bullish setup, but investors will want to see stronger momentum before calling a sustained recovery.

Valuation-wise, RKLB stock is priced at 50.43 times forward sales, sitting way above the sector average and its historical median.

Rocket Lab’s Shares Slip Despite Impressive Q2 Numbers

Rocket Lab’s latest quarterly report gave investors plenty to like, and a few things to keep an eye on. The company delivered a record $234 million in Q2 revenue, up 62% year-over-year (YOY), as demand remained strong across both its launch and space systems businesses.

Rocket Lab’s backlog jumped 137% YOY to a record $2.36 billion. Including deals signed during the period since quarter-end, the company has already secured more than $1 billion in new contracts in Q3 across launch and space systems. That gives Rocket Lab a much stronger revenue pipeline heading into the rest of the year.

The mix is also shifting. Launch accounted for 40% of backlog in Q2, while space systems increased to 60%. Government customers now make up 43% of the backlog, compared with 57% for commercial customers, a notable change from the roughly 49%/51% split in Q1.

Profitability showed some progress too. Non-GAAP gross margin climbed to 41.5% from 36.9% a year earlier, helped by better fixed-cost absorption on Electron launches and a favorable product mix. On a GAAP basis, Rocket Lab’s loss narrowed to $0.08 per share from $0.13 a year ago. Still, the company remains firmly in the red, meaning the path to profitability could take longer than some investors had hoped.

There was better news on the adjusted EBITDA front. The loss narrowed to $8.8 million from $11.8 million in Q1, beating Rocket Lab’s own guidance for a $20 million to $26 million loss by a wide margin.

On the launch side, Rocket Lab secured more than $437 million in new launch contracts across Electron, HASTE, and Neutron during Q2 and the period since, taking its total launch backlog to more than 90 missions.

And Rocket Lab is clearly thinking beyond launches. It ended Q2 with $2.4 billion in cash, cash equivalents, marketable securities and restricted cash, giving it significant financial firepower for growth. The company completed its acquisitions of Mynaric and Motiv and announced its planned acquisition of Iridium Communications, a move aimed at expanding Rocket Lab into space-based communications and applications. Mynaric’s contribution to the business, however, also pushed operating expenses higher in Q2.

For Q3, Rocket Lab expects revenue of $250 million to $265 million, non-GAAP gross margin of 35% to 37%, and an adjusted EBITDA loss of $17 million to $23 million. 

Meanwhile, Wall Street analysts tracking the company anticipate losses to be $0.07 per share in Q3, while revenue is projected to be around $255.6 million. Looking ahead to fiscal 2026, confidence builds further. Losses are anticipated to narrow by 31.6% annually to -$0.26 per share, and further shrink by 15.4% YOY to -$0.22 per share.

What Do Analysts Expect for Rocket Lab Stock?

Cantor Fitzgerald is still pretty bullish on Rocket Lab, even with the uncertainty around Neutron’s launch timeline. Recently, the brokerage firm raised its price target to $122 from $96 while maintaining an “Overweight” rating. Cantor Fitzgerald sees Neutron as potentially the most direct and viable alternative to SpaceX’s Falcon 9 once operational. More importantly, strong demand could improve Neutron’s unit economics and help Rocket Lab move toward profitability faster.

Overall, analysts are upbeat on RKLB, with a “Strong Buy” consensus, and that’s an upgrade from a “Moderate Buy” rating two months back. Of the 18 analysts tracking the stock, 13 have a “Strong Buy,” one advises a “Moderate Buy,” and the remaining four are on the sidelines with a “Hold” rating.

RKLB has an average price target of $114.23, implying 42.5% upside potential from current levels. On the bullish end, the Street-high target of $150 points to even sharper gains of 87.15%.